FDA Approved: BENLYSTA — Original Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved Benlysta (belimumab) from GlaxoSmithKline LLC as the original application for treatment of systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• BENLYSTA (belimumab)

Snippet

ORIG AP for BENLYSTA (BELIMUMAB)